Effect of anxiety and depression on the fatigue of patients with a permanent pacemaker

Maria Polikandrioti, Konstantinos Tzirogiannis, Sofia Zyga, Ioannis Koutelekos, Georgios Vasilopoulos, Paraskevi Theofilou, George Panoutsopoulos, Maria Polikandrioti, Konstantinos Tzirogiannis, Sofia Zyga, Ioannis Koutelekos, Georgios Vasilopoulos, Paraskevi Theofilou, George Panoutsopoulos

Abstract

Introduction: Permanent cardiac pacemakers (PPM) are the most common treatment for severe symptomatic bradycardia. This implanted life-saving device may involve a severe psychological burden to recipients or aggravate their symptoms such as fatigue. The aim of the study was to explore the effect of anxiety and depression on fatigue of patients' with a PPM.

Material and methods: The study group consisted of 250 patients with a PPM. Data collected included: a) patients' characteristics, b) the Hospital Anxiety and Depression Scale (HADS) and c) the Fatigue Assessment Scale (FAS).

Results: High levels of anxiety and depression were observed in 27.2% and 14.0% of the sample, respectively. Regarding the fatigue total score it was found that 25% of the participants had a score higher than 26. Accordingly, with regard to physical and mental fatigue, 25% of enrolled patients had a score higher than 20 and 8, respectively. These values indicate moderate to low levels of fatigue. Furthermore, there was a statistically significant association between anxiety/depression and the total score of fatigue as well as between anxiety/depression and physical and mental fatigue (p < 0.001 for all associations).

Conclusions: Socio-demographic and patients' clinical characteristics are related to anxiety and depression. Understanding the association between psychological burden and fatigue after implantation as well as factors associated with these variables will help health professionals to provide beneficial care for PPM patients that will significantly contribute to better device outcomes.

Keywords: anxiety-depression; fatigue; pacemaker implantation.

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. Brunner M, Olschewski M, Geibel A, Bode C, Zehender M. Long-term survival after pacemaker implantation. Prognostic importance of gender and baseline patient characteristics. Eur Heart J. 2004;25:88–95.
    1. Ghojazadeh M, Azami Aghdash S, Sohrab Navi Z, Kolahdouzan K. Cardiovascular patients’ experiences of living with pacemaker: qualitative study. ARYA Atheroscler. 2015;11:281–8.
    1. Uslan DZ, Tleyjeh IM, Baddour LM, et al. 2008 Temporal trends in permanent pacemaker implantation: a population-based study. Am Heart J. 2008:896–903.
    1. Vellone E, Rega ML, Galletti C, Morchio A, Alvaro R, Sansoni J. Anxiety and depression before and after a pacemaker implantation: a comparative study. Int Nurs Persp. 2008;8:93–9.
    1. Bradshaw PJ, Stobie P, Knuiman MV, Briffa TG, Hobbs MS. Life expectancy after implantation of a first cardiac permanent pacemaker (1995-2008): a population-based study. Int J Cardiol. 2015;190:42–6.
    1. Iliou MC, Blanchard JC, Lamar Tanguy A, Cristofini P, Ledru F. Cardiac rehabilitation in patients with pacemakers and implantable cardioverter defibrillators. Monaldi Arch Chest Dis. 2016;86:756.
    1. Lampert R. Managing with pacemakers and implantable cardioverter defibrillators. Circulation. 2013;128:1576–85.
    1. Duru F, Büchi S, Klaghofer R, et al. How different from pacemaker patients are recipients of implantable cardioverter-defibrillators with respect to psychosocial adaptation, affective disorders, and quality of life? Heart. 2001;85:375–9.
    1. Leone St. A disabling combination: fatigue and depression. Br J Psychiatry. 2010;197:86–7.
    1. Zigmond AS, Snaith RP. The Hospital Anxiety And Depression Scale. Acta Psychiatr Scand. 1983;67:361–70.
    1. Mystakidou K, Tsilika E, Parpa E, Katsouda E, Galanos A, Vlahos L. The Hospital Anxiety and Depression Scale in Greek cancer patients: psychometric analyses and applicability. Support Care Cancer. 2004;12:821–5.
    1. Zyga S, Alikari V, Sachlas A, et al. Assessment of fatigue in end stage renal disease patients undergoing hemodialysis: prevalence and associated factors. Med Arh. 2015;69:376–80.
    1. Ozcan C, Jahangir A, Friedman PA, et al. Long-term survival after ablation of the atrioventricular node and implantation of a permanent pacemaker in patients with atrial fibrillation. N Engl J Med. 2001;344:1043–51.
    1. Aydemir O, Ozmen E, Küey L, et al. Psychiatric morbidity and depressive symptomatology in patients with permanent pacemakers. Pacing Clin Electrophysiol. 1997;20:1628–32.
    1. Goodwin GM. Depression and associated physical diseases and symptoms. Dialogues Clin Neurosci. 2006;8:259–65.
    1. Wood MA, Ellenbogen KA. Cardiology patient pages. Cardiac pacemakers from the patient’s perspective. Circulation. 2002;105:2136–8.
    1. Hart PL. Women’s perceptions of coronary heart disease: an integrative review. J Cardiovasc Nurs. 2005;20:170–6.
    1. Lockyer L. Women’s interpretation of their coronary heart disease symptoms. Eur J Cardiovasc Nurs. 2005;4:29–35.
    1. Altemus M, Sarvaiya N, Epperson CN. Sex differences in anxiety and depression clinical perspectives. Front Neuroendocrinol. 2014;35:320–30.
    1. Toogood G. Pacemaker therapies in cardiology. Aust Fam Physician. 2007;36:518–9. 521-4.
    1. Malm D, Hallberg LR. Patients’ experiences of daily living with a pacemaker: a grounded theory study. J Health Psychol. 2006;11:787–98.
    1. Malm D, Karlsson JE, Fridlund B. Effects of a self-care program on the health-related quality of life of pacemaker patients: a nursing intervention study. Can J Cardiovascular Nurs. 2007;17:15–26.
    1. Polikandrioti M, Goudevenos J, Michalis L, et al. Correlation between the type of acute coronary syndrome with the needs of hospitalized patients. Glob J Health Sci. 2016;8:126–8.
    1. Aqeel M, Shafquat A, Salahuddin N. Pacemaker patients’ perception of unsafe activities: a survey. BMC Cardiovascular Disorders. 2008;8:31.
    1. Xhulia D, Gerta J, Dajana Z, et al. Needs of hemodialysis patients and factors affecting them. Glob J Health Sci. 2016;8:109–20.
    1. Ballenger JC. Anxiety and depression: optimizing treatments. Prim Care Companion J Clin Psychiatry. 2000;2:71–9.
    1. Addington AM, Gallo JJ, Ford DE, Eaton WW. Epidemiology of unexplained fatigue and major depression in the community: the Baltimore ECA follow-up, 1981-1994. Psychol Med. 2001;31:1037–44.
    1. Lawrie SM, MacHale SM, Cavanagh JT, O’Carroll RE, Goodwin GM. The difference in patterns of motor and cognitive function in chronic fatigue syndrome and severe depressive illness. Psychol Med. 2000;30:433–42.
    1. Craig T, Kakumanu S. Chronic fatigue syndrome: evaluation and treatment. Am Fam Physician. 2002;65:1083–90.

Source: PubMed

Sponsoren und Mitarbeiter

Krankheiten

Drogeninterventionen

3
Abonnieren